Hidden hearing aid? new implant could restore speech without visible parts

NCT ID NCT06459765

Completed Disease control Sponsor: MED-EL Elektromedizinische Geräte GesmbH Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new type of cochlear implant that is completely hidden under the skin, with no external parts. Thirty adults with severe hearing loss received the implant to see if it improved their ability to understand speech. Participants took word and sentence tests, hearing checks, and quality-of-life surveys before and after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mi2000 totally implantable cochlear implant (device)
What this could lead to: If successful, this device could provide a fully hidden cochlear implant that improves speech understanding in quiet and noise, offering a more discreet and convenient option for people with severe hearing loss.
What could go wrong: This is a small, completed study with only 30 participants, so results may not apply to everyone. The device is new and may have unknown risks or technical issues, and long-term benefits are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING LOSS, SENSORINEURAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hearing Loss, Sensorineural sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEARING LOSS, SENSORINEURAL

Contacts and locations

Locations

AKH Wien

Vienna, 1090, Austria
CHU Liège

Liège, 4000, Belgium
LMU Munich

München, Bavaria, 81377, Germany
The Institute of Physiology and Pathology of Hearing

Nadarzyn, 05-830, Poland
UKW Würzburg

Würzburg, Bavaria, 97080, Germany
UZA Antwerpen

Antwerp, 2650, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.